michael_becker

Relmada Therapeutics appoints new chief financial officer

pharmafile | May 17, 2016 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing chief financial officer, relmada 

Michael D. Becker has been appointed the new chief financial officer at Relmada Therapeutics.

Becker joined the company in 2014 as senior vice president of finance and corporate development. In his new role, he will be responsible for all corporate finance and accounting activities for the company.

Having previously held senior roles in the financial services industry, Becker has previous experience in the life sciences sector. He served as president and chief executive officer at Cytogen Corporation, beginning his role there in 2002. Prior to joining Relmada, he was the founder and president of consulting firm MDB Communications LLC since 2008.

Advertisement

Sergio Traversa, CEO at Relmada, says: “We are pleased to expand Michael’s role as we prepare for the continued growth and expansion of our operations at Relmada. Since joining the Company in 2014, Michael has consistently managed responsibilities of expanding scope and complexity. As we advance our pipeline through several critical upcoming milestones, sound financial planning and discipline will be even more important elements of our success. Michael’s outstanding experience in both the biotechnology and financial services sectors together with his deep understanding of our business make him uniquely suited to lead our finance team moving forward.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content